In the housing market, consumers need more tools to assess risks from climate change. As insurers improve their risk ...

SELLAS Life Sciences Virtual R&D Day – October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...

SELLAS Life Sciences Group climbs higher after a premarket drop, reversing course as investors seem to react to new ...

As Polymarket and Kalshi continue to grow in popularity, they have worked with social media accounts claiming to be breaking ...

The State Attorney's Office has concluded its investigation into a shooting by an off-duty officer on a trucker during what ...

The sports betting industry is constantly facing new challenges, so STATSCORE takes a deep dive into one of the most ...

Only two men can tell us if Elon Musk and Trump are truly, as of December 2025, “friends.” But the formal definition I used ...

Sharing anecdotes is not misinformation, but it can produce miscalibration, making to harder to make sense of the facts, writes Catherine De Soto.

Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the fin ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Investing now moves at lightning speed, with quotes refreshing instantly and news spreading faster than most people can react ...

Analyst warns 99% may lose funds on prediction markets as insiders exploit data access and artificial volume signals.